• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl advises listed Swedencare on acquisition and directed new issues of shares

  • Home
  • Latest news
  • Cases and transactions
  • 2021
  • Lindahl advises listed Swedencare on acquisition of animal health group in North America and on directed new issues of shares

Lindahl acts as legal advisor when Swedencare AB (publ) acquires the Vetio Group consisting of eight companies in the US and Canada from the US private equity firm Thompson Street Capital Partners and a number of minority shareholders. The Vetio Group, which operates in development and manufacturing of dietary supplements, dermatological products and pharmaceuticals for the animal health market, has its headquarters in St. Louis, Missouri, and conducts development and manufacturing in Jupiter, Florida, and in Montreal, Quebec. The Vetio Group is the leading animal health contract development manufacturing organization (CDMO) in North America. Closing of the transaction occurrs on 1 July 2021. The purchase price amounts to approximately 181.5 million USD and consists of a cash amount of approximately 179 million USD and an issue in kind of 184,190 shares in Swedencare to the selling members of management (representing 2.3 million USD) with payment as contribution in kind through transfer of units in one of the target companies. The group will continue to be run by existing management members, which by way of the issuance of new shares will become minority shareholders in Swedencare.

Further, Lindahl advises Swedencare on a directed share issue of 11,954,200 shares, corresponding to approximately 1,150 MSEK. The shares in the directed cash share issue is subscribed for in equal parts by the German listed company Symrise AG and a Swedish financial investor. The proceeds raised by Swedencare in the cash share cash issue will be used to partially finance the acquisition of the Vetio Group. Symrise AG is a leading actor in taste development for the global animal feed market and will after the share issue have an ownership of approximately five percent of the shares in Swedencare. Swedencare’s intention is to, with Symrise AG as a strategic owner, be able to accelerate its business, primarily in animal feed collaborations, and, with the new financial investor, gain access to a global network and expertise in M&A and business development.

Swedencare develops, produces, markets and sells premium products in the global and fast-growing market for animal health products for cats, dogs and horses. Swedencare’s product groups are represented on approximately fifty markets around the world and are sold through subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland, and through an external distribution network. Swedencare’s shares are listed on Nasdaq First North Growth Market. Through the acquisition of the Vetio Group, Swedencare gains a strong position in the manufacture and development of premium brands for the animal health market in the US and Canada.

Lindahl’s team consisted of Johan Herrström, Annika Brandt, Henrik Nilsson, Victoria Volny, Christian Sundén, Jesper Fredriksson, Johanna Svensson, André Persson and Pontus Söderberg. Lindahl worked on the acquisition together with Wiggin and Dana in New York and McMillan in Toronto and Montreal, all members of the same global network, TerraLex.

 

Related

  • 4/6/2021 4:48:43 PM Lindahl advises Swedencare on acquisition of Rx Vitamins
  • 12/17/2020 9:35:38 AM Lindahl advises Swedencare on new acquisition
  • 9/25/2020 2:49:56 PM Lindahl advises Swedencare on acquisitions in England and USA
  • 6/25/2020 12:10:18 PM Lindahl advises Swedencare on acquisition and directed share issue

Contact

  • Johan Herrström

    Malmö

    johan.herrstrom@lindahl.se +46 730 399 246
  • Annika Brandt

    Malmö

    annika.brandt@lindahl.se +46 704 215 004
  • Christian Sundén

    Malmö

  • Jesper Fredriksson

    Malmö

    jesper.fredriksson@lindahl.se +46 723 571 439
  • Johanna Karlsson

    Malmö

  • André Persson

    Malmö

    andre.persson@lindahl.se +46 723 571 467
  • Pontus Söderberg

    Malmö

    pontus.soderberg@lindahl.se +46 723 571 422
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience